Literature DB >> 27880748

CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.

Juan L Rodriguez, Cheryll C Thomas, Greta M Massetti, Debra Duquette, Lindsay Avner, John Iskander, Muin J Khoury, Lisa C Richardson.   

Abstract

Although many efforts in cancer prevention and control have routinely focused on behavioral risk factors, such as tobacco use, or on the early detection of cancer, such as colorectal cancer screening, advances in genetic testing have created new opportunities for cancer prevention through evaluation of family history and identification of cancer-causing inherited mutations. Through the collection and evaluation of a family cancer history by a trained health care provider, patients and families at increased risk for a hereditary cancer syndrome can be identified, referred for genetic counseling and testing, and make informed decisions about options for cancer risk reduction (1). Although hereditary cancers make up a small proportion of all cancers, the number of affected persons can be large, and the level of risk among affected persons is high. Two hereditary cancer syndromes for which public health professionals have worked to reduce the burden of morbidity and mortality are hereditary breast and ovarian cancer syndrome (HBOC) and Lynch syndrome.

Entities:  

Mesh:

Year:  2016        PMID: 27880748     DOI: 10.15585/mmwr.mm6546a3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  4 in total

1.  Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: Estimates from the 2015 National Health Interview Survey.

Authors:  Marie T Kumerow; Juan L Rodriguez; Shifan Dai; Katherine Kolor; Melissa Rotunno; Lucy A Peipins
Journal:  Prev Med       Date:  2022-04-20       Impact factor: 4.637

2.  Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.

Authors:  Samantha Greenberg; Saundra S Buys; Sandra L Edwards; Whitney Espinel; Alison Fraser; Amanda Gammon; Brent Hafen; Kimberly A Herget; Wendy Kohlmann; Camille Roundy; Carol Sweeney
Journal:  Cancer Med       Date:  2019-09-18       Impact factor: 4.452

Review 3.  Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.

Authors:  Ridgely Fisk Green; Mary Ari; Katherine Kolor; W David Dotson; Scott Bowen; Nancy Habarta; Juan L Rodriguez; Lisa C Richardson; Muin J Khoury
Journal:  Genet Med       Date:  2018-06-15       Impact factor: 8.822

Review 4.  From public health genomics to precision public health: a 20-year journey.

Authors:  Muin J Khoury; M Scott Bowen; Mindy Clyne; W David Dotson; Marta L Gwinn; Ridgely Fisk Green; Katherine Kolor; Juan L Rodriguez; Anja Wulf; Wei Yu
Journal:  Genet Med       Date:  2017-12-14       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.